Tardive dyskinesia (TD) is a movement disorder. It results from using medicines used to treat psychiatric problems, like schizophrenia. TD causes repeating movements you cannot control. They may affect the face, limbs, or trunk.
It is treated with medicine. Medicines that cause TB may be stopped or changed. Some supplements may also lower the risk of problems. Some people may benefit from deep brain stimulation if other methods do not help.
These therapies may provide benefit:
Editorial process and description of evidence categories can be found at EBSCO NAT Editorial Process.
Talk to your doctor about all herbs or supplements you are taking. Some may interact with your treatment plan or health conditions. Some supplements discussed here have certain concerns such as:
Branched-chain Amino Acids
A1. Richardson MA1, Bevans ML, et al. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry. 2003;160(6):1117-1124.
B1. Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF. Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72(5):615-621.
B2. Zheng W, Xiang YQ, Ng CH, Ungvari GS, Chiu HF, Xiang YT. Extract of Ginkgo biloba for tardive dyskinesia: meta-analysis of randomized controlled trials. 2016;49(3):107-111.
B3. Soares-Weiser K, Rathbone J, et al. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018 Mar 19;3:CD000208.
B4. Bhidayasiri R, Jitkritsadakul O, et al. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm. J Neurol Sci. 2018 Jun 15;389:67-75.
C1. Shamir E, Barak Y, Plopsky I, Zisapel N, Elizur A, Weizman A. Is melatonin treatment effective for tardive dyskinesia? J Clin Psychiatry. 2000;61(8):556-568.
C2. Shamir E, Barak Y, Shalman I, et al. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry. 2001;58(11):1049-1052.
C3. Castro F, Carrizo E, Prieto de Rincón D et al. Effectiveness of melatonin in tardive dyskinesia. Invest Clin. 2011;52(3):252-260.
D1. Adelufosi AO, Abayomi O, Ojo TM. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2015;(4):CD010501.
E1. Bergman H, Walker DM, et al. Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia. Health Technol Assess. 2017 Aug;21(43):1-218.
F1. Soares-Weiser K, Maayan N, Bergman H. Vitamin E for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018;1:CD000209. F2. Pham DQ, Plakogiannis R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann Pharmacother. 2005 Dec;39(12):2065-72.
G1. Emsley R, Niehaus DJ, et al. The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial. Schizophr Res. 2006 May;84(1):112-120.
Last reviewed December 2019 by EBSCO NAT Review Board
Eric Hurwitz, DC
Last Updated: 6/26/2020